261 related articles for article (PubMed ID: 9634812)
1. Genomic sciences and the medicine of tomorrow.
Drews J
Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
[No Abstract] [Full Text] [Related]
2. How will biotechnology fare in pharma's big plan?
Nat Biotechnol; 1996 Nov; 14(11):1515. PubMed ID: 9634811
[No Abstract] [Full Text] [Related]
3. Unlocking the money-making potential of RNAi.
Howard K
Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
[No Abstract] [Full Text] [Related]
4. Biotech drugs come of age; policymakers take notice.
Iglehart JK
Health Aff (Millwood); 2006; 25(5):1202-3. PubMed ID: 16966714
[No Abstract] [Full Text] [Related]
5. Biotech's billion dollar breakthrough.
Stipp D
Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
[No Abstract] [Full Text] [Related]
6. China's biotech is starting to bloom.
Stipp D
Fortune; 2002 Sep; 146(4):126-30, 132, 134. PubMed ID: 12195673
[No Abstract] [Full Text] [Related]
7. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
8. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
9. R&D deals boom in 2004.
Lawrence S
Nat Biotechnol; 2005 Sep; 23(9):1036. PubMed ID: 16151383
[No Abstract] [Full Text] [Related]
10. Cures on the cob.
Roosevelt M
Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
[No Abstract] [Full Text] [Related]
11. Can personalized drugs pay off?
Stipp D
Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
[No Abstract] [Full Text] [Related]
12. Biotech industry tries to recover from 2-year lull.
Brower V
J Natl Cancer Inst; 2003 Mar; 95(5):348-9. PubMed ID: 12618496
[No Abstract] [Full Text] [Related]
13. Pharmacogenetics--pivotal to the future of the biopharmaceutical industry.
Foot E; Kleyn D; Palmer Foster E
Drug Discov Today; 2010 May; 15(9-10):325-7. PubMed ID: 20298799
[No Abstract] [Full Text] [Related]
14. Gene therapy: cursed or inching towards credibility?
Branca MA
Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
[No Abstract] [Full Text] [Related]
15. There's still gold in them thar pills.
O'Reilly B
Fortune; 2001 Jul; 144(2):58-62, 66-8, 70. PubMed ID: 11471355
[No Abstract] [Full Text] [Related]
16. A new prescription for your portfolio.
Clifford L; O'Keefe B; Stires D
Fortune; 2001 Jul; 144(2):74-6, 78, 80. PubMed ID: 11471357
[No Abstract] [Full Text] [Related]
17. The biotechnology bubble machine.
Rasnick D
Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
[No Abstract] [Full Text] [Related]
18. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
19. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
20. Designs that enrich lives.
Link A; Stark H
Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
[No Abstract] [Full Text] [Related]
[Next] [New Search]
